Presentation and Status in Health Basket
| Presentation | Basket | Yarpa | Pharmasoft |
|---|---|---|---|
|
Pre-filled Pen 2 mg X 4 (PEN) |
|
11098 | 16911 |
Related information
Dosage
The recommended dose is 2 mg exenatide once weekly,for self administration by the patient. Each kit should be used by one person only and is for single use. See prescribing information for full details.
Indications
Bydureon is indicated for treatment of type 2 diabetes mellitus in combination with Metformin,Sulphonylurea,Metformin and sulphonylurea in adults who have not achieved adequate glycaemic control on maximally tolerated doses of these oral therapies.
Contra-Indications
Hypersensitivity to the active substance or to any of the excipients.
Special Precautions
Must not be administered by intravenous or intramuscular injection. Should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. May cause weight loss, acute pancreatitis.
See prescribing information for full details.
Side Effects
Injection site reactions, Hypoglycaemia, Nausea, Rapid weight loss, patients may develop antibodies to exenatide.
See prescribing information for full details.
Overdose
Effects of overdoses with exenatide (based on exenatide twice daily clinical studies) included severe nausea, severe vomiting and rapidly declining blood glucose concentrations. In the event of overdose, appropriate supportive treatment should be initiated according to the patient’s clinical signs and symptoms.
